Calcium-Based Phosphate Binder Induces Osteomalacia in a Rat Model of Adynamic Bone Disease
Calcified Tissue International · 2025
DOI: 10.1007/s00223-025-01448-9 ↗Kurz gefasst
Fachartikel in der Zeitschrift Calcified Tissue International, 2025. Verfasst von Tânia Priante de Oliveira Truyts und 7 weiteren Autor:innen. Beteiligte Einrichtung: LIM 16 Laboratório de Fisiopatologia Renal, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, Av. Dr. Arnaldo, 455, 3º…. Hauptthemen laut MEDLINE: Osteomalacia, Calcium Carbonate, Bone Diseases. Die Arbeit nennt 22 Literaturangaben.
Abstract (Originalsprache)
Hyperphosphatemia is a common complication of chronic kidney disease (CKD) and occurs in both high- and low-turnover bone disorders. While phosphate (P) control is known to reduce adverse effects, most supporting studies have focused on high-turnover models. This study evaluates the effects of two P binders-calcium carbonate (CaCO₃) and sevelamer carbonate-on laboratorial markers and bone histomorphometry in a low-turnover bone disease model. Wistar rats underwent 5/6 nephrectomy and total parathyroidectomy (Nx + PTx) to induce low-turnover bone disease. Animals were assigned to 4 groups: Sham, untreated Nx + PTx, Nx + PTx + CaCO₃, and Nx + PTx + sevelamer. After 8 weeks, we performed biochemical analysis, bone histomorphometry, gene expression (SOST, β-catenin, DKK-1), immunohistochemistry (sclerostin, β-catenin, FGF23, DKK-1), and apoptosis assays. Bone histology confirmed low-turnover disease in Nx + PTx rats, which also developed CKD and hyperphosphatemia. Both P binders effectively reduced serum P levels, but only CaCO₃ corrected hypocalcemia. Notably, CaCO₃ treatment led to increased osteoid parameters, elevated osteoblast surface and absence of tetracycline labeling - hallmarks of osteomalacia. Moreover, CaCO₃ increased osteoblast apoptosis. In a rat model of low-turnover bone disease with normal dietary P, high-dose CaCO₃ impaired bone mineralization and induced osteomalacia. These findings highlight potential risks of calcium-based phosphate binders in patients with low bone turnover and hyperphosphatemia, supporting the need for careful clinical consideration and monitoring.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- LIM 16 Laboratório de Fisiopatologia Renal, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, Av. Dr. Arnaldo, 455, 3º floor, room 3342, São Paulo, 01246-903, SP, Brazil.
- Programa de Pós-Graduação em Medicina, Universidade Nove de Julho - UNINOVE, Sao Paulo, Brazil.
- LIM 16 Laboratório de Fisiopatologia Renal, Faculdade de Medicina, Hospital das Clínicas HCFMUSP, Universidade de São Paulo, Av. Dr. Arnaldo, 455, 3º floor, room 3342, São Paulo, 01246-903, SP, Brazil. lucienem@usp.br.
ORCID-Profile: Luciene Machado Dos Reis
Zitieren
APA
de Oliveira Truyts, T. P., Ferreira, J. C., Neves, K. R., Dominguez, W. V., Elias, R. M., Moyses, R. M. A., Jorgetti, V., & Dos Reis, L. M. (2025). Calcium-Based Phosphate Binder Induces Osteomalacia in a Rat Model of Adynamic Bone Disease. Calcified Tissue International. https://doi.org/10.1007/s00223-025-01448-9
Vancouver
de Oliveira Truyts TP, Ferreira JC, Neves KR, Dominguez WV, Elias RM, Moyses RMA, et al. Calcium-Based Phosphate Binder Induces Osteomalacia in a Rat Model of Adynamic Bone Disease. Calcified Tissue International. 2025. doi:10.1007/s00223-025-01448-9
BibTeX
@article{deOliveiraTruyts2025,
author = {de Oliveira Truyts, Tânia Priante and Ferreira, Juliana Cunha and Neves, Katia Rodrigues and Dominguez, Wagner Vasques and Elias, Rosilene Motta and Moyses, Rosa Maria Affonso and Jorgetti, Vanda and Dos Reis, Luciene Machado},
title = {Calcium-Based Phosphate Binder Induces Osteomalacia in a Rat Model of Adynamic Bone Disease},
journal = {Calcified Tissue International},
year = {2025},
doi = {10.1007/s00223-025-01448-9}
}
EUVIMED